Updated Jul 16, 2026
Kim Jean Jinsun is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Kim Jean Jinsun is associated with Avidity Biosciences, Inc., a biotechnology company focused on developing therapies for diseases using its proprietary Avidity platform. Specific details about their role or background are not widely available in public sources.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-27 | RNAM | Avidity Biosciences, Inc. | D — Derivative transaction | 6.7K | — |
Kim Jean Jinsun is associated with Avidity Biosciences, Inc., a biotechnology company focused on developing therapies for diseases using its proprietary Avidity platform. Specific details about their role or background are not widely available in public sources.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kim Jean Jinsun profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.